Aquestive Therapeutics, Inc. · NASDAQ:AQST

Davis Matthew W. had 5,303 Aquestive Therapeutics, Inc. shares withheld for tax (Form 4)

Traded Nov 10, 2026 · Filed Nov 12, 2026

On Nov 10, 2026, Davis Matthew W. (Chief Development Officer) had 5,303 Aquestive Therapeutics, Inc. shares withheld for tax at US$3.52 for US$18,667, leaving 94,697 shares. Filed Nov 12, 2026 (Form 4).

Withheld for tax
5,303 shares
Price
US$3.52
Value
US$18,667
Holding after
94,697 shares
Trading plan
No
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 10, 2026Common StockShares withheld for tax5,303US$3.5294,697Direct

Source

Download original · View original at SEC

Related